China Pharma (NYSE:CPHI) Now Covered by StockNews.com

Stock analysts at StockNews.com started coverage on shares of China Pharma (NYSE:CPHIGet Free Report) in a research note issued to investors on Tuesday. The brokerage set a “hold” rating on the stock.

China Pharma Trading Up 6.0 %

Shares of NYSE:CPHI opened at $0.22 on Tuesday. The company has a current ratio of 0.79, a quick ratio of 0.26 and a debt-to-equity ratio of 0.22. China Pharma has a twelve month low of $0.13 and a twelve month high of $0.51. The company has a 50-day moving average price of $0.21 and a two-hundred day moving average price of $0.21.

China Pharma Company Profile

(Get Free Report)

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.

Further Reading

Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.